Last reviewed · How we verify
NCT04136613
Utility of Immediate Post Placental Insertion of Intrauterine Device During Cesarean Delivery
NA trial testing Copper Intra uterine contarceptive device ( Cu-T 380A) in Contraception Behavior in 150 participants. Completed in 1 June 2019.
1 January 2019
Quick facts
| Lead sponsor | Taghreed Alhaidari |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 150 |
| Start date | 1 September 2015 |
| Primary completion | 1 January 2019 |
| Estimated completion | 1 June 2019 |
| Sites | 1 location across Iraq |
Drugs / interventions tested
- Copper Intra uterine contarceptive device ( Cu-T 380A)
Conditions studied
- Contraception Behavior — all drugs for Contraception Behavior →
Sponsor
Taghreed Alhaidari
Who can join
Adults 18 to 45, female only, with Contraception Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Iraq is a country that ranks 33rd around world population growth rate. Meanwhile it is one of the counties in the middle east with the highest fertility rate, In addition to the considerable number of unintended pregnancy mainly in postpartum period. The less use of family planning methods, the higher the fertility rate and the less interpregnancy interval which will carry an obvious more risk to the mother and the fetus especially if the cesarean delivery rate shown an increase trend as the case in Iraq. For that reason, contraception needs to be practiced in this critical period and an intrauterine contraceptive device ( IUD), the most commonly used reversible method of contraception worldwide could be an excellent choice during this period. There were few evidences available about the safety and feasibility on practicing this type of contraception when we did start three years ago and no previous evidences in Iraq about practicing this method at the immediate postpartum period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04136613
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Contraception Behavior
Currently open trials in the same condition.
- NCT06943209 — SAPLAI : Assessing the faiSAbility of a Peer-to-peer Contraceptive Education Program on Social Networks Aimed at 15- to · recruiting
- NCT06852508 — TwySHE - An Mhealth Peer-navigator Intervention to Increase PrEP and Contraceptive Use · NA · recruiting
- NCT06579781 — Evaluation of Parent Toolkit 2.0 (Morehouse Family Health Study) · NA · recruiting
- NCT06296797 — Patient-centered Information on Permanent Contraception · NA · recruiting
- NCT06608862 — The Impact of Hormonal Contraceptive Use and Lifestyle Factors on Fracture Risk and Bone Quality in Young Female Adults · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04136613 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Taghreed Alhaidari
- Last refreshed: 18 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04136613.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing